Zobrazeno 61 - 70
of 238
pro vyhledávání: '"Marc Espié"'
Autor:
C De Bazelaire, A de Roquancourt, L Cahen-Doidy, E Huon De Kermadec, M Albiter, E Hindié, Marc Espié, J Wassermann, C Cuvier, S Banayan, S Giacchetti, David Groheux, F Coussy, Marjorie Lalloum, E Bourstyn
Publikováno v:
Cancer Research. 73:P6-12
Background: Inflammatory breast carcinomas have poor prognosis even in the absence of evident synchronous metastases. 18F-FDG PET/CT is not recommended in initial staging but could improve the sensibility of synchronous metastases detection and the m
Publikováno v:
La Presse Médicale. 42:1405-1411
Low vitamin D plasmatic rates have been correlated to an increased risk of developing cancer. It has been proved that vitamin D could facilitate cell differentiation and have anti-inflammatory, anti-angiogenic and pro-apoptotic effects. Epidemiologic
Autor:
Mathieu Hatt, A de Roquancourt, David Groheux, Laetitia Vercellino, Florence Coussy, Michel Marty, Marc Espié, Caroline Cuvier, Sylvie Giacchetti, Elif Hindié
Publikováno v:
British Journal of Cancer
Background: Pathologic complete response (pCR) to neoadjuvant treatment (NAT) is associated with improved survival of patients with HER2+ breast cancer. We investigated the ability of interim positron emission tomography (PET) regarding early predict
Autor:
Marc Espié, Sylvie Giacchetti, Marion Chapellier, Aurélie Scemama, Patricia de Cremoux, Mariana Varna, Raphael Richard, Cédric de Bazelaire, Isabelle Thomassin, Eric de Kerviler
Publikováno v:
European Radiology. 23:2420-2431
To evaluate the accuracy of the apparent diffusion coefficient (ADC) provided by diffusion-weighted imaging (DWI) in predicting the response to neoadjuvant chemotherapy (NACT) at baseline in patients according to their breast tumour phenotypes. This
Publikováno v:
EMC - Ginecología-Obstetricia. 49:1-19
El cancer de mama afecta a 50.000 mujeres al ano en Francia. Es la causa de 11.000 fallecimientos. Asi como la incidencia sigue aumentando o se estabiliza, la mortalidad empieza a disminuir. Los principales factores de riesgo de desarrollar un cancer
Autor:
Anne de Roquancourt, Marie-Elisabeth Toubert, Marc Espié, Pascal Merlet, Laetitia Vercellino, Marc Delord, Elif Hindié, David Groheux, Anne-Sophie Hamy, Sylvie Giacchetti, Cédric de Bazelaire
Publikováno v:
JNCI Journal of the National Cancer Institute
Background This study prospectively evaluated the yield of fluorodeoxyglucose positron emission tomography/computed tomography (18FDG-PET-CT) in patients with clinical stages II and III breast cancer and the impact of PET-CT results on prognosis. Met
Autor:
S Delaloge, P Bertheau, M-C Mathieu, Marc Espié, M Marty, Bernard Asselain, J-Y Pierga, O Tembo, E. Brain, Sylvie Giacchetti, P. de Cremoux
Publikováno v:
Cancer Research. 72:P1-14
Background: Trastuzumab is indicated in neoadjuvant setting in locally advanced HER2 positive breast cancer patients (Gianni L. Lancet 2010). There is no data on the impact of the use of neoadjuvant Trastuzumab (T) compared to adjuvant T on survival.
Autor:
Caroline Cuvier, Florence Coussy, M. Albiter, Marc Espié, Raphaël Porcher, Marjorie Lalloum, A S Hamy, Sylvie Giacchetti, A de Roquancourt
Publikováno v:
Cancer Research. 72:P4-13
Background: Use of hormone replacement therapy (HRT) has been associated with an increased risk of breast cancer. Few studies focus on correlation between HRT and in situ breast cancer A large cohort study, the Million Women Study (Reeves GK et al. L
[Academic carriers in oncology and radiotherapy: Explanations for the readers of Bulletin du Cancer]
Autor:
Jean-Charles, Soria, Gérard, Bastian, Lina, Bolotine, Gilles, Calais, Jocelyn, Céraline, Patricia, de Cremoux, Marc, Espié, Lucie, Karayan-Tapon, Anne, Laprie, Jean-Jacques, Mazeron, Sylvie, Négrier, Henri, Roché
Publikováno v:
Bulletin du cancer. 103(9)
Autor:
Delphine, Cochereau, Sabrina, Da Costa, Christine, Le Maignan, Hélène, Gauthier, Jérôme, Cochereau, Marc, Espié, Sylvie, Giacchetti, Luis, Teixeira
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2016, 103 (5), pp.444-454. ⟨10.1016/j.bulcan.2016.02.002⟩
Bulletin du Cancer, John Libbey Eurotext, 2016, 103 (5), pp.444-454. ⟨10.1016/j.bulcan.2016.02.002⟩
International audience; Methotrexate represents the standard intrathecal treatment of breast cancer meningeal carcinomatosis. However, its optimal schedule remains undefined. The aim of the present study was to evaluate results obtained with the meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e0d7fa412136221bfa6977ae009ac4fb
https://hal.archives-ouvertes.fr/hal-01872757
https://hal.archives-ouvertes.fr/hal-01872757